Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Horizon Robotics Launches Innovative Urban Driving Assistance System
- Exploring Education Opportunities: A Global Perspective
- Transforming Global Education: New Trends for Students
- Malaysia's Infrastructure Surge: A Testament to BRI Growth
- Investigation Sparked into General Motors' Leadership Actions
- Understanding Legal Actions Against E.L.F. Beauty and Investor Options
- Understanding the Shareholder Rights in Bancorp Lawsuit
- Ready Capital Investors: Know Your Rights and Options
- Ongoing Investigation of DocGo: Allegations Uncovered and More
- Fluence Energy Faces Class Action: Key Details for Investors
- Investors Warily Eye Class Action Against Viatris - VTRS News
- Investors Urged to File Claims in AppLovin Class Action
- Exploring Innovations in Smart Mobility at Major Trade Fair
- Tejon Ranch Co. Calls on Shareholders to Uphold Growth Vision
- e.l.f. Beauty's Investors Can Join Important Class Action
- Navigating Legal Rights for Everus Construction Investors
- Insights into NAPCO Security Technologies, Inc. Legal Matters
- Storelocal's Tenant Protection Program Expands to 600+ Facilities
- Understanding the Fluence Energy Securities Class Action Lawsuit
- Baijiayun Group Inspires Health and Vitality Through Spring Run
- Berkshire Biomedical's Final Webinar to Unveil COPA™ Innovations
- Life Flower Dispensary Expands: New Store in RiNo, Denver
- RND Automation Expands Product Portfolio with QuickPouch Buy
- Medtronic Expands Diabetes Management with Simplera Sync™ Sensor
- Portland General Electric Announces Increased Dividend for Investors
- International Battery Metals Ltd. Enhances Corporate Strategy
- Actinium Pharmaceuticals Seeks Justice for ATNM Investors
- Zynex, Inc. Investors - Your Rights and Legal Options Explored
- Zenas BioPharma Faces Class Action for Misleading Investors
- Ibotta, Inc. Faces Legal Action: What Investors Should Know
- Investigation Update on Light & Wonder, Inc. Securities Claims
- Exploring Legal Avenues for The Bancorp, Inc. Investors
- Opportunities for AppLovin Corporation Investors in Legal Actions
- Corales Puntacana Championship: A New Era Until 2027
- Navigating Securities Class Actions: Trade Desk, Inc. Insights
- Iovance Biotherapeutics Expands Employee Compensation with Stock Options
- Unlock Crypto Success: Explore PAIRMiner's Innovative Solutions
- Oak Valley Bancorp Unveils Strong First Quarter Results
- Rosen Law Firm Launches Investigation into UnitedHealth Group
- Join the Excitement at Gold Bar Whiskey's Record-Breaking Event
- Route 66 Neon Park Celebrates Historic Beauty in Missouri
- MedEx Ambulance Addresses Security Incident Resolution Steps
- Last Chance to Join XploraDEX's Groundbreaking Presale
- Hapbee Technologies Delays Financial Filings, Seeks Order
- Ring Energy Sees Strong Q1 Performance and Future Growth
- Upcoming Financial Results Call: Integra LifeSciences Insights
- Coherent Launches Axon FL: Revolutionizing Mini2P Imaging
- 23andMe Shares Update on Asset Sale Process and Data Protection
- Meritage Hospitality Q1 2025 Results and Future Prospects
- Safety Shot, Inc. Delays Caring Brands Spin-Off Announcement